Review
doi: 10.1007/978-1-4684-9072-5_8.
Molecular pharmacology of hallucinogens
- PMID: 4872761
- DOI: 10.1007/978-1-4684-9072-5_8
Item in Clipboard
Review
Molecular pharmacology of hallucinogens
Recent Adv Biol Psychiatry.
1968.
No abstract available
Similar articles
-
Behavioural models of psychosis.Br J Psychiatry. 1969 Jan;115(518):55-68. doi: 10.1192/bjp.115.518.55. Br J Psychiatry. 1969. PMID: 5781961 No abstract available.
-
Failure of N,N-dimethyltryptamine to evoke tolerance in cats.Biol Psychiatry. 1973 Dec;7(3):213-20. Biol Psychiatry. 1973. PMID: 4519415 No abstract available.
-
N,N-dimethyltryptamine--a possible relationship to schizophrenia?Adv Biochem Psychopharmacol. 1974;11(0):299-313. Adv Biochem Psychopharmacol. 1974. PMID: 4602668 Review. No abstract available.
-
Biochemical abnormalities associated with schizophrenia.Br J Psychiatry. 1975;Spec No 9:41-7. Br J Psychiatry. 1975. PMID: 1102037 Review. No abstract available.
-
The mechanism of action of hallucinogenic drugs on a possible serotonin receptor in the brain.Int Rev Neurobiol. 1970;12:207-33. doi: 10.1016/s0074-7742(08)60062-8. Int Rev Neurobiol. 1970. PMID: 4918144 Review. No abstract available.
Cited by
-
Facilitation of avoidance acquisition by LSD-25. Possible effects on drive modulating systems.Psychopharmacologia. 1972;25(2):146-51. doi: 10.1007/BF00423191. Psychopharmacologia. 1972. PMID: 5048515 No abstract available.